Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP005 Gel for Actinic Keratosis on the Hand
NCT00544297Phase 2Completed
- Sponsor
- Peplin
- Start
- Oct 2007
- Primary completion
- Jan 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Peplin. Started Oct 2007; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00544297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544297.